Beta Bionics, Inc.
$12.91
▼
-0.8%
2026-04-21 05:34:01
www.betabionics.com
NGM: BBNX
Explore Beta Bionics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$576.08 M
Current Price
$12.91
52W High / Low
$32.71 / $8.8
Stock P/E
—
Book Value
$6.48
Dividend Yield
—
ROCE
-24.07%
ROE
-40.26%
Face Value
—
EPS
$-1.81
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
420
Beta
—
Debt / Equity
2.54
Current Ratio
8.66
Quick Ratio
7.96
Forward P/E
-4.57
Price / Sales
3.92
Enterprise Value
$181.4 M
EV / EBITDA
-2.59
EV / Revenue
1.81
Rating
Buy
Target Price
$23.09
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 2. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
| 3. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 4. | CeriBell, Inc. | $21.13 | — | $797.62 M | — | -33.07% | -30.83% | $24.33 / $10.85 | $4.14 |
| 5. | QT Imaging Holdings, Inc. | $7 | — | $83.45 M | — | -29.28% | 1363.27% | $19.05 / $1.86 | $0.54 |
| 6. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 7. | Sight Sciences, Inc. | $4.36 | — | $220.88 M | — | -35.58% | -50.74% | $9.24 / $2.4 | $1.2 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 32.12 M | 27.25 M | 23.24 M | 17.64 M | 20.44 M | — |
| Operating Profit | -16.12 M | -17.04 M | -19.87 M | -18.64 M | -13.04 M | — |
| Net Profit | -13.47 M | -14.21 M | -16.87 M | -28.66 M | -18.11 M | — |
| EPS in Rs | -0.3 | -0.32 | -0.38 | -0.65 | -0.41 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 100.25 M | 65.12 M | 11.99 M | 0.18 M |
| Operating Profit | -71.68 M | -45.25 M | -35.85 M | -65.84 M |
| Net Profit | -73.2 M | -54.76 M | -44.1 M | -64.75 M |
| EPS in Rs | -1.65 | -1.23 | -0.99 | -1.46 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 328.74 M | 149.65 M | 110.04 M | 35.53 M |
| Total Liabilities | 41.13 M | 395 M | 313.14 M | 205.56 M |
| Equity | 287.61 M | -245.36 M | -203.1 M | -170.03 M |
| Current Assets | 267.9 M | 132.92 M | 103.62 M | 28.47 M |
| Current Liabilities | 30.92 M | 21.15 M | 10.61 M | 8.87 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -50.92 M | -48.27 M | -32.45 M | -60.21 M |
| Investing CF | -162.81 M | -3.48 M | -69.69 M | -0.77 M |
| Financing CF | 214.87 M | 55.62 M | 101.03 M | 56.78 M |
| Free CF | -56.22 M | -51.67 M | -32.85 M | -60.98 M |
| Capex | -5.3 M | -3.4 M | -0.4 M | -0.77 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 53.94% | 442.93% | 6601.12% | — |
| Earnings Growth % | -33.68% | -24.17% | 31.89% | — |
| Profit Margin % | -73.02% | -84.08% | -367.64% | -36173.74% |
| Operating Margin % | -71.5% | -69.48% | -298.87% | -36784.36% |
| Gross Margin % | 55.4% | 55.11% | 52.59% | 100% |
| EBITDA Margin % | -68.63% | -65.98% | -281.44% | -35000% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.